Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

Nils Venhoff; Nora M. Effelsberg; Ulrich Salzer; Klaus Warnatz; Hans Hartmut Peter; Dirk Lebrecht; Michael Schlesier; Reinhard E. Voll; Jens Thiel

doi:10.1371/journal.pone.0037626

Loading metrics

Open Access

Peer-reviewed

Research Article

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

Nils Venhoff ,

Contributed equally to this work with: Nils Venhoff, Nora M. Effelsberg

Affiliation Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
⨯
Nora M. Effelsberg ,

Contributed equally to this work with: Nils Venhoff, Nora M. Effelsberg

Affiliation Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
⨯
Ulrich Salzer,

Affiliations Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany, Centre for Chronic Immunodeficiency (CCI), University Hospital Freiburg, Freiburg, Germany
⨯
Klaus Warnatz,

Affiliations Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany, Centre for Chronic Immunodeficiency (CCI), University Hospital Freiburg, Freiburg, Germany
⨯
Hans Hartmut Peter,

Affiliations Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany, Centre for Chronic Immunodeficiency (CCI), University Hospital Freiburg, Freiburg, Germany
⨯
Dirk Lebrecht,

Affiliation Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
⨯
Michael Schlesier,

Affiliations Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany, Centre for Chronic Immunodeficiency (CCI), University Hospital Freiburg, Freiburg, Germany
⨯
Reinhard E. Voll,

Affiliations Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany, Centre for Chronic Immunodeficiency (CCI), University Hospital Freiburg, Freiburg, Germany
⨯
Jens Thiel

* E-mail: jens.thiel@uniklinik-freiburg.de

Affiliations Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany, Centre for Chronic Immunodeficiency (CCI), University Hospital Freiburg, Freiburg, Germany
⨯

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

Nils Venhoff,
Nora M. Effelsberg,
Ulrich Salzer,
Klaus Warnatz,
Hans Hartmut Peter,
Dirk Lebrecht,
Michael Schlesier,
Reinhard E. Voll,
Jens Thiel

Published: May 21, 2012
https://doi.org/10.1371/journal.pone.0037626

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Immunosuppressives
Is the Subject Area "Immunosuppressives" applicable to this article?

Thanks for your feedback.
Wegener granulomatosis
Is the Subject Area "Wegener granulomatosis" applicable to this article?

Thanks for your feedback.
Cyclophosphamide
Is the Subject Area "Cyclophosphamide" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Polysaccharides
Is the Subject Area "Polysaccharides" applicable to this article?

Thanks for your feedback.